CA Stock MarketDetailed Quotes
DRUG Bright Minds Biosciences Inc
- 61.000
- +9.400+18.22%
15min DelayMarket Closed Jan 2 15:29 ET
426.33MMarket Cap-93.85P/E (TTM)
61.000High54.660Low1.62KVolume54.660Open51.600Pre Close95.28KTurnover108.00052wk High0.06%Turnover Ratio6.99MShares1.29052wk Low-0.65EPS TTM160.79MFloat Cap108.000Historical HighLossP/E (Static)2.64MShs Float1.290Historical Low-0.65EPS LYR12.29%Amplitude--Dividend TTM77.02P/B1Lot Size--Div YieldTTM
Bright Minds Biosciences Inc Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 73.66%-1.85M | 61.32%-463.17K | 114.55%240.16K | 46.77%-805.09K | 69.14%-822.09K | 48.30%-7.02M | 43.74%-1.2M | 42.33%-1.65M | 58.51%-1.51M | 46.20%-2.66M |
| Net income from continuing operations | 61.99%-2.8M | 49.38%-773.44K | 115.77%229.9K | 72.00%-574.14K | 27.88%-1.68M | 50.74%-7.37M | 48.40%-1.53M | 45.14%-1.46M | 54.31%-2.05M | 51.93%-2.34M |
| Operating gains losses | -122.33%-10.13K | -109.17%-14.98K | 69.64%-39.61K | -59.39%2.17K | 500.01%42.3K | 117.52%45.35K | 417.62%163.44K | -467.93%-130.47K | -23.72%5.33K | 103.68%7.05K |
| Depreciation and amortization | 1.25%73.36K | 5.01%19.02K | 0.00%18.11K | -0.01%18.11K | 0.01%18.11K | 1,100.10%72.45K | 200.02%18.11K | --18.11K | --18.11K | --18.11K |
| Asset impairment expenditure | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | -27.11%839.77K | -47.51%210.24K | -22.56%183.94K | 656.58%226.64K | -54.78%218.95K | 31.66%1.15M | 1,238.78%400.5K | -19.04%237.54K | -89.70%29.96K | 85.55%484.14K |
| Other non cashItems | -54.71%8.95K | -31.14%2.61K | -72.88%1.24K | -60.14%2.13K | -50.93%2.97K | -32.88%19.75K | 74.23%3.79K | --4.58K | --5.33K | --6.06K |
| Change In working capital | 104.23%39.81K | 136.57%93.39K | 52.35%-153.43K | -200.16%-479.99K | 168.74%579.85K | -230.05%-941.72K | -130.26%-255.36K | 35.77%-322K | -11.94%479.25K | -419.24%-843.6K |
| -Change in receivables | -111.15%-13.24K | -149.46%-32.99K | 862.32%536.01K | -2,061.29%-508.21K | -108.35%-8.06K | 360.33%118.8K | 173.02%66.7K | -162.80%-70.31K | 197.00%25.91K | 344.04%96.5K |
| -Change in prepaid assets | -238.17%-188.94K | -238.82%-158.31K | -215.89%-43K | 181.02%16.76K | -169.82%-4.38K | 3,519.30%136.74K | 235.54%114.04K | 662.24%37.11K | -136.29%-20.68K | -75.93%6.27K |
| -Change in payables and accrued expense | 120.21%241.99K | 165.28%284.69K | -123.84%-646.44K | -97.58%11.46K | 162.58%592.29K | -256.30%-1.2M | -142.79%-436.1K | 53.28%-288.8K | -7.76%474.02K | -535.25%-946.38K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 73.66%-1.85M | 61.32%-463.17K | 114.55%240.16K | 46.77%-805.09K | 69.14%-822.09K | 48.30%-7.02M | 43.74%-1.2M | 42.33%-1.65M | 58.51%-1.51M | 46.20%-2.66M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -62.98%810.57K | -8.83%-23.56K | -2.18%-21.96K | -2.17%-21.96K | -61.05%878.04K | -57.86%2.19M | -100.43%-21.65K | -279.08%-21.49K | -1,376.13%-21.49K | 1,806.39%2.25M |
| Net issuance payments of debt | -4.20%-89.73K | -10.23%-23.86K | -2.18%-21.96K | -2.17%-21.96K | -2.18%-21.96K | -1,102.35%-86.11K | -187.14%-21.65K | ---21.49K | 32.84%-21.49K | ---21.49K |
| Net common stock issuance | -26.08%900K | --0 | --0 | --0 | -26.08%900K | -69.83%1.22M | --0 | --0 | --0 | --1.22M |
| Proceeds from stock option exercised by employees | -99.97%302 | --302 | --0 | --0 | --0 | -44.87%1.09M | --0 | --0 | --0 | 817.78%1.09M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 96.63%-26.98K | --0 | --0 | --0 | ---26.98K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -62.98%810.57K | -8.83%-23.56K | -2.18%-21.96K | -2.17%-21.96K | -61.05%878.04K | -57.86%2.19M | -100.43%-21.65K | -279.08%-21.49K | -1,376.13%-21.49K | 1,806.39%2.25M |
| Net cash flow | ||||||||||
| Beginning cash position | -41.97%6.75M | -23.86%6.19M | -38.66%5.93M | -39.69%6.76M | -41.97%6.75M | -41.15%11.63M | -5.90%8.13M | -15.66%9.67M | -25.84%11.21M | -41.15%11.63M |
| Current changes in cash | 78.50%-1.04M | 60.08%-486.73K | 113.05%218.2K | 46.09%-827.05K | 113.67%55.96K | 42.38%-4.83M | -141.53%-1.22M | 41.33%-1.67M | 57.90%-1.53M | 91.53%-409.36K |
| Effect of exchange rate changes | 125.84%11.72K | 110.14%16.58K | -69.64%39.61K | 59.39%-2.17K | -500.01%-42.3K | -117.52%-45.35K | -417.62%-163.44K | 467.93%130.47K | 23.72%-5.33K | -103.68%-7.05K |
| End cash Position | -15.23%5.72M | -15.23%5.72M | -23.86%6.19M | -38.66%5.93M | -39.69%6.76M | -41.97%6.75M | -41.97%6.75M | -5.90%8.13M | -15.66%9.67M | -25.84%11.21M |
| Free cash from | 73.66%-1.85M | 61.32%-463.17K | 114.55%240.16K | 46.77%-805.09K | 69.14%-822.09K | 48.30%-7.02M | 43.74%-1.2M | 42.33%-1.65M | 58.51%-1.51M | 46.20%-2.66M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data